Literature DB >> 31584122

Prevailing Effects of Ibutilide on Fast Delayed Rectifier K+ Channel.

Sodikdjon A Kodirov1,2,3,4, Vladimir L Zhuravlev5,6, Johannes Brachmann5,7.   

Abstract

Effects of ibutilide, a class III antiarrhythmic drug, on delayed rectifier potassium currents (IK) in freshly isolated guinea pig ventricular myocytes were studied. Experiments were performed using the whole-cell configuration of patch-clamp technique under blockade of L-type calcium currents (Cav1). Ibutilide at concentrations ranging between 10 nM and 100 µM inhibited IKr in dose-dependent manner with a half maximal effective concentration of 2.03 ± 0.74 µM (n = 5-10). The amplitude of tail currents activated by prepulse to + 20 mV was decreased from 253 ± 52 to 130 ± 25 pA (n = 8, p < 0.01) in the presence of 1 µM ibutilide. The envelope test revealed time-dependent changes in ratio of IK-tail/ΔIK during 0.2-2 s pulse durations in the absence of drug. With ibutilide, regardless of pulse duration, a relatively constant ratio was estimated, indicative of predominant involvement of IKr component. The slow IKs persisted to greater extent even at 100 μM ibutilide revealing a distinguishable selectivity toward the IKr component.

Entities:  

Keywords:  Antiarrhythmic agents; HERG; Tail current

Mesh:

Substances:

Year:  2019        PMID: 31584122     DOI: 10.1007/s00232-019-00098-x

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  45 in total

Review 1.  Efficacy of ibutilide for termination of atrial fibrillation and flutter.

Authors:  K A Ellenbogen; H F Clemo; B S Stambler; M A Wood; J T VanderLugt
Journal:  Am J Cardiol       Date:  1996-10-17       Impact factor: 2.778

2.  Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.

Authors:  G J Amos; C Abrahamsson; G Duker; L Hondeghem; M Palmer; L Carlsson
Journal:  Cardiovasc Res       Date:  2001-02-01       Impact factor: 10.787

3.  Ibutilide for the control of refractory ventricular tachycardia and ventricular fibrillation in patients with myocardial ischemia and hemodynamic instability.

Authors:  Mauricio Sendra-Ferrer; Mario D Gonzalez
Journal:  J Cardiovasc Electrophysiol       Date:  2019-01-11

4.  Fast inactivation causes rectification of the IKr channel.

Authors:  P S Spector; M E Curran; A Zou; M T Keating; M C Sanguinetti
Journal:  J Gen Physiol       Date:  1996-05       Impact factor: 4.086

5.  Modulation of HCN channels in lateral septum by nicotine.

Authors:  Sodikdjon A Kodirov; Michael Wehrmeister; Luis V Colom
Journal:  Neuropharmacology       Date:  2014-02-26       Impact factor: 5.250

6.  Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome.

Authors:  F Sesti; S A Goldstein
Journal:  J Gen Physiol       Date:  1998-12       Impact factor: 4.086

7.  Effects of antiarrhythmic agents classified as class III group on ischaemia-induced myocardial damage in canine hearts.

Authors:  T Sano; S Sugiyama; K Taki; Y Hanaki; Y Shimada; T Ozawa
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

Review 8.  Molecular Basis of Functional Myocardial Potassium Channel Diversity.

Authors:  Jeanne M Nerbonne
Journal:  Card Electrophysiol Clin       Date:  2016-03-24

9.  Ionic mechanism of ibutilide in human atrium: evidence for a drug-induced Na+ current through a nifedipine inhibited inward channel.

Authors:  K S Lee; E W Lee
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

10.  Effects of ibutilide fumarate, a novel antiarrhythmic agent, and its enantiomers on isolated rabbit myocardium.

Authors:  M G Cimini; M N Brunden; J K Gibson
Journal:  Eur J Pharmacol       Date:  1992-11-03       Impact factor: 4.432

View more
  1 in total

Review 1.  Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels.

Authors:  Raminta Vaiciuleviciute; Daiva Bironaite; Ilona Uzieliene; Ali Mobasheri; Eiva Bernotiene
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.